Sodio Cloruro Fresenius Kabi Italia 0,9%, solvente per uso parenterale, Samyr placebo (saline solution), SAMYR 400 mg/5ml polvere e solvente per soluzione iniettabile
MYL-1603N-3002
Phase 3 small_molecule active
Quick answer
Sodio Cloruro Fresenius Kabi Italia 0,9%, solvente per uso parenterale, Samyr placebo (saline solution), SAMYR 400 mg/5ml polvere e solvente per soluzione iniettabile for Major Depression Disorders is a Phase 3 program (small_molecule) at Mylan dura GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Mylan dura GmbH
- Indication
- Major Depression Disorders
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active